Browsing by Ajou Author

이, 현우(Lee, Hyun Woo) Currently indexed
[School of Medicine / Graduate School of Medicine] - [Hematology-Oncology]

Author IDs

ORCID
-
WOS
-
SCOPUS
-

Showing results 1 to 20 of 76

This table browses all dspace content
Pub YearTitleAuthor(s)
2019Capecitabine plus Oxaliplatin as a Second-Line Therapy for Advanced Biliary Tract Cancers: A Multicenter, Open-Label, Phase II Trial이현우
2019Increased CMTM6 can predict the clinical response to PD-1 inhibitors in non-small cell lung cancer patients고영화, 이현우, 정준호, 한재호, 함석진
2019The impact of systemic treatment on brain metastasis in patients with non-small-cell lung cancer: A retrospective nationwide population-based cohort study강석윤, 안미선, 이현우
2019Capecitabine plus oxaliplatin versus gemcitabine plus oxaliplatin as first-line therapy for advanced biliary tract cancers: a multicenter, open-label, randomized, phase III, noninferiority trial이현우
2019Does the extent of brain metastasis affect outcome of non-small cell lung cancer patients treated with chemotherapy?강석윤, 안미선, 이현우, 최용원, 최진혁
2019PD-L1 protein expression in non-small-cell lung cancer and its relationship with the hypoxia-related signaling pathways: A study based on immunohistochemistry and RNA sequencing data고영화, 이수진, 이현우, 정준호, 한재호, 함석진
2019The Impact of Systemic Treatment on Brain Metastasis in Patients with Non-Small-Cell Lung Cancer: A Nationwide Population-Based Cohort Study이현우
2019Investigating the Feasibility of Targeted Next-Generation Sequencing to Guide the Treatment of Head and Neck Squamous Cell Carcinoma이현우
2019The role of surgical resection before palliative chemotherapy in advanced gastric cancer강석윤, 박준성, 손상용, 신승수, 안미선, 이현우, 정성현, 최용원, 최진혁, 한상욱, 허훈
2018Should combination chemotherapy be used in all advanced gastric cancer patients?강석윤, 안미선, 이현우, 최용원, 최진혁
2018Prognostic significance of neutrophil lymphocyte ratio and platelet lymphocyte ratio in gastric cancer patients who underwent palliative chemotherapy강석윤, 안미선, 이현우, 최용원, 최진혁
2018An open-label, multicenter, phase II single arm trial of osimertinib in non-small cell lung cancer patients with uncommon EGFR mutation (KCSG-LU15-09)이현우
2018Investigating the feasibility of targeted next-generation sequencing to guide the treatment of head and neck squamous cell carcinoma.이현우
2018Consensus guidelines for the definition of the end stage of disease and last days of life and criteria for medical judgment이현우
2018OA10.05: An Open-Label, Multicenter, Phase II Single Arm Trial of Osimertinib in NSCLC Patients with Uncommon EGFR Mutation(KCSG-LU15-09)이현우
2018469: Therapy-induced senescence associated secretory phenotype enhances breast cancer cell invasion and stemness via CXCR1/2-CXCR1/2 ligands axis강석윤, 박준성, 박태준, 안미선, 이현우, 정성현, 최용원, 최진혁
2018P1.15-14: Pneumonia in Patients with Lung Cancer of South Korea: A Nationwide Population Based Study이현우, 정준호, 허재성
2018EGFR Exon 19 Deletion is Associated With Favorable Overall Survival After First-line Gefitinib Therapy in Advanced Non-Small Cell Lung Cancer Patients강석윤, 고영화, 박준성, 신승수, 이현우, 정성현, 최용원, 최진혁, 한재호
2018Strong immunoexpression of dickkopf-1 is associated with response to bortezomib in multiple myeloma강석윤, 김장희, 박준성, 안미선, 이현우, 정성현, 최용원, 최진혁, 한재호
2018Social Media Use for Cancer Education at a Community-Based Cancer Center in South Korea이현우, 전미선, 허재성
1 2 3 4

Browse